PhotoniCare

PhotoniCare

Private
Durham, North CarolinaHealthcare & Life Scienceshttps://photoni.care/

Last Round

Series B

Dec 3, 2024

Total Funding Raised

$7.58M

Company Overview

PhotoniCare is a medical device company that has developed the OtoSight Middle Ear Scope, which uses light-based technology to see through the eardrum to help diagnose middle ear infections.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

middle ear imagingOptical Coherence TomographyOCTear infection diagnosisotitis media diagnosispediatric diagnosticsdigital otoscopehandheld diagnostic toolsmart otoscopemedical imaging devicenon-invasive imagingFDA clearancemedical device salesreimbursement supportCPT code supportSmall Business Innovation ResearchSBIR

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

PhotoniCare Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

PhotoniCare Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series BDec 3, 2024
Series ASep 3, 2020
GrantSep 3, 2020
GrantAug 6, 2019
SeedJun 1, 2017
Accelerator
Mar 1, 2016

Key People

Founding team and executive leadership

John Boeschenstein

Chief Executive Officer

Executive Team

Eric Benson

Chief Financial Officer

Executive Team

PhotoniCare Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 22, 2025

    Grew 18% QoQ from 22 to 26 employees.

  • Dec 13, 2024

    Grew 16% QoQ, from 19 to 22 employees.

PhotoniCare Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

PhotoniCare Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about PhotoniCare's valuation, stock price, and market status.

Firmographic Details

HeadquartersDurham, North Carolina
Employee Range20
Year Founded2013
Last FundingDec 3, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.